Kurse werden geladen...
Prognose
Kaufen | 5 |
Halten | 0 |
Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
STRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call Transcript
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Jules Abraham - CORE IR Dolev Rafaeli - Chief Executive Officer John Gillings - VP of Finance Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Jeremy Pearlman - Maxim Group Operator Good afternoon, and welcome to the STRATA Skin Sciences First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode.» Mehr auf seekingalpha.com
STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
HORSHAM, Pa., May 14, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2025, and provides a corporate update.» Mehr auf globenewswire.com
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference
HORSHAM, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will participate in the D. Boral Capital Inaugural Global Conference. The conference is being held on May 14, 2025, at The Plaza Hotel, 768 Fifth Avenue, New York, NY 10019.» Mehr auf globenewswire.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 6,30 Mio | 0,62% |
Bruttoeinkommen | 3,37 Mio | 18,13% |
Nettoeinkommen | −2,25 Mio | 27,96% |
EBITDA | −1,86 Mio | 34,01% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 8,40 Mio€ |
Anzahl Aktien | 4,17 Mio |
52 Wochen-Hoch/Tief | 3,31€ - 1,83€ |
Dividenden | Nein |
Beta | 0,71 |
KGV (PE Ratio) | −1,05 |
KGWV (PEG Ratio) | −0,07 |
KBV (PB Ratio) | 3,61 |
KUV (PS Ratio) | 0,29 |
Unternehmensprofil
Name | STRATA SKIN SCIENCES INC |
CEO | Dr. Dolev Rafaeli Ph.D. |
Mitarbeiter | 106 |
Assets entdecken
Shareholder von STRATA SKIN SCIENCES INC investieren auch in folgende Assets